Barry Rosen, MD
Gynecologic Oncology · Dearborn, MINPI 1902285752
Payments from drug & device makers
What this record shows
7 manufacturers reported payments, led by AstraZeneca at 36.3% of the total. That places this record below the midpoint for gynecologic oncology clinicians in MI, where the typical reported total is $894.
Across 7 payments — averaging $38.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$99
- Lemaitre Vascular, Inc.$72
- Tempus AI, Inc$30
- Boston Scientific$23
- Stryker$20
- Baxter Healthcare$19
- plus $10 from 1 others
What the payments were for
- Food & beverage$16460%
- Education$10940%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 1 | $99 |
| Lemaitre Vascular, Inc. | 1 | $72 |
| Tempus AI, Inc | 1 | $30 |
| Boston Scientific | 1 | $23 |
| Stryker | 1 | $20 |
| Baxter Healthcare | 1 | $19 |
| Clovis Oncology, Inc. | 1 | $10 |
How this compares
$273 in reported general payments places this provider in the 20th percentile of 43 gynecologic oncology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prochlorperazine Maleate | 32 | $317 |
| Dexamethasone | 18 | $300 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 11 | $136 |
| Omeprazole | 26 | $103 |
| Medroxyprogesterone Acetate | 11 | $80 |
| Ondansetron Hcl | 14 | $35 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Dearborn
- Robert MorrisDetroit$807K
- Ira WinerDetroit$25K
- Morgan TaylorDetroit$23K
- Radhika GogoiDetroit$12K
- Douglas PugmireRochester Hills$9K
- Zaid Al-WahabGrosse Pointe$9K
- Gregory SuttonSaginaw$8K
- Ahmad AwadaDetroit$5K
- Kevin BraderWyoming$5K
- Mae ZakhourGrand Rapids$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.